The FDA recalled the Symbiq pump touchscreen (Hospira Inc.) on Oct. 29. The screen may not properly respond to user selection, may have a delayed response, or register a value other than the one selected by the user, an FDA press release said.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.